IL1F10 and Sepsis: Furthermore, treatment with IL‐38 obviously decreased the mortality rate of CLP‐induced sepsis in mice, while blocking IL‐38 reduced the survivals of septic mice, thus identifying IL‐38 as a potential therapeutic agent against septic complications.